STOCK TITAN
  1. Home
  2. Sec-filings
  3. SBRA
  4. [Form 4] Sabra Health Care REIT, Inc. Insider Trading Activity

Sabra Health Care (SBRA) grants 8,310 stock units to director Ann Kono

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Kono Ann reported acquisition or exercise transactions in this Form 4 filing.

Sabra Health Care REIT, Inc. director Ann Kono received an equity award of 8,310 restricted stock units of common stock as compensation. The grant was made at no cash cost to her and is structured to vest in equal monthly installments beginning July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the next annual stockholders' meeting.

Each unit represents the right to receive one share of Sabra’s common stock. Following this grant, Kono has an aggregate 68,186 stock units, including the 8,310 unvested units from this award and 55,016 units that have already vested but for which share delivery has been deferred.

Positive

  • None.

Negative

  • None.

Insights

Director received a routine stock unit grant as board compensation, with no open‑market buying or selling.

Director Ann Kono was granted 8,310 restricted stock units of Sabra Health Care REIT, Inc. common stock at a price of $0.00 per unit. This is a compensation-related equity award, not a market purchase, and therefore carries a weaker information signal than open‑market buying.

The units vest monthly from July 17, 2026 through the earlier of June 17, 2027 or the day before the next annual meeting, aligning board compensation with ongoing service. After this grant, Kono holds 68,186 stock units, combining unvested and vested-but-deferred units, indicating continuing equity exposure to Sabra shares.

Insider Kono Ann
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 8,310 $0.00 $0.00
Holdings After Transaction: Common Stock — 68,186 shares (Direct)
Footnotes (2)
  1. F1. Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan. The units vest in equal monthly installments beginning July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the date of the next annual stockholders' meeting.
  2. F2. Includes 8,310 unvested stock units and 55,016 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.
Restricted stock units granted 8,310 units Equity award to director Ann Kono on June 17, 2026
Grant price $0.00 per unit Compensation-related stock unit grant
Total stock units after grant 68,186 units Director Ann Kono’s aggregate stock units following transaction
Vested but deferred units 55,016 units Vested stock units with deferred payment
Unvested units from this grant 8,310 units Newly granted restricted stock units
restricted stock units financial
"Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2009 Performance Incentive Plan financial
"Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan."
vest financial
"The units vest in equal monthly installments beginning July 17, 2026 and ending on the earlier of June 17, 2027."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
deferred financial
"Includes 8,310 unvested stock units and 55,016 stock units that have vested but the payment of which has been deferred."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What did Sabra Health Care REIT (SBRA) director Ann Kono receive in this Form 4?
Director Ann Kono received an award of 8,310 restricted stock units of Sabra Health Care REIT common stock. The grant was made at $0.00 per unit as equity compensation rather than a market purchase.

How and when do Ann Kono’s new Sabra Health Care (SBRA) stock units vest?
The 8,310 restricted stock units vest in equal monthly installments starting July 17, 2026. Vesting continues until the earlier of June 17, 2027 or the day before Sabra’s next annual stockholders’ meeting.

How many Sabra Health Care (SBRA) stock units does Ann Kono hold after this transaction?
After this award, Ann Kono holds a total of 68,186 stock units. This includes 8,310 unvested units from the new grant and 55,016 units that have vested but whose share delivery has been deferred.

Does this Sabra Health Care (SBRA) Form 4 show an open-market stock purchase or sale?
No. The Form 4 reports a grant of restricted stock units, coded as a compensation-related acquisition. The transaction price is listed as $0.00 per share, indicating no open-market buying or selling occurred here.

What does each Sabra Health Care (SBRA) stock unit in this grant represent?
Each unit represents the right to receive one share of Sabra common stock. Some units are unvested and will vest over time, while other units have vested but their share delivery has been deferred according to the plan’s terms.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kono Ann
(Last)(First)(Middle)
C/O SABRA HEALTH CARE REIT, INC.
1781 FLIGHT WAY
(Street)
TUSTIN CALIFORNIA 92782
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Sabra Health Care REIT, Inc. [ SBRA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/17/2026A8,310(1)A$068,186(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan. The units vest in equal monthly installments beginning July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the date of the next annual stockholders' meeting.
2. Includes 8,310 unvested stock units and 55,016 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.
Remarks:
Exhibit List: Exhibit 24 - Power of Attorney
/s/ Michael Costa, as Attorney-in-Fact06/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR